- Home
- REFR vs MDCX Comparison
REFR vs MDCX Comparison
Compare REFR & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFR
- MDCX
- Stock Information
- Founded
- REFR 1965
- MDCX 2008
- Country
- REFR United States
- MDCX United States
- Employees
- REFR N/A
- MDCX N/A
- Industry
- REFR Multi-Sector Companies
- MDCX
- Sector
- REFR Miscellaneous
- MDCX
- Exchange
- REFR Nasdaq
- MDCX Nasdaq
- Market Cap
- REFR 51.8M
- MDCX 50.8M
- IPO Year
- REFR N/A
- MDCX N/A
- Fundamental
- Price
- REFR $1.79
- MDCX $2.36
- Analyst Decision
- REFR
- MDCX Strong Buy
- Analyst Count
- REFR 0
- MDCX 2
- Target Price
- REFR N/A
- MDCX $23.50
- AVG Volume (30 Days)
- REFR 56.4K
- MDCX 417.1K
- Earning Date
- REFR 11-06-2025
- MDCX 11-22-2025
- Dividend Yield
- REFR N/A
- MDCX N/A
- EPS Growth
- REFR N/A
- MDCX N/A
- EPS
- REFR N/A
- MDCX N/A
- Revenue
- REFR $1,222,239.00
- MDCX N/A
- Revenue This Year
- REFR N/A
- MDCX N/A
- Revenue Next Year
- REFR N/A
- MDCX N/A
- P/E Ratio
- REFR N/A
- MDCX N/A
- Revenue Growth
- REFR N/A
- MDCX N/A
- 52 Week Low
- REFR $0.93
- MDCX $1.79
- 52 Week High
- REFR $2.31
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- REFR 61.80
- MDCX 47.80
- Support Level
- REFR $1.40
- MDCX $2.33
- Resistance Level
- REFR $1.94
- MDCX $2.70
- Average True Range (ATR)
- REFR 0.17
- MDCX 0.21
- MACD
- REFR 0.04
- MDCX -0.02
- Stochastic Oscillator
- REFR 66.67
- MDCX 26.15
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.